{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:45:43Z","timestamp":1791215143909,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["EKFS P17\/\/07\/\/A83\/06"],"award-info":[{"award-number":["EKFS P17\/\/07\/\/A83\/06"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015510","name":"Infrastructures en Biologie Sant\u00e9 et Agronomie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008656","name":"Fondation Innovations en Infectiologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008656","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["CA 06\/12\/08"],"award-info":[{"award-number":["CA 06\/12\/08"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-05-CEXC-008"],"award-info":[{"award-number":["ANR-05-CEXC-008"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["30\/03\/09"],"award-info":[{"award-number":["30\/03\/09"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["2009-143"],"award-info":[{"award-number":["2009-143"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["2009\/183"],"award-info":[{"award-number":["2009\/183"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["2007\/306"],"award-info":[{"award-number":["2007\/306"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["2007\/09"],"award-info":[{"award-number":["2007\/09"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["2008\/354"],"award-info":[{"award-number":["2008\/354"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","award":["2011\/132"],"award-info":[{"award-number":["2011\/132"]}],"id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1053\/j.gastro.2012.04.006","type":"journal-article","created":{"date-parts":[[2012,4,10]],"date-time":"2012-04-10T02:13:42Z","timestamp":1334024022000},"page":"223-233.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Mutations That Alter Use of Hepatitis C Virus Cell Entry Factors Mediate Escape From Neutralizing Antibodies"],"prefix":"10.1053","volume":"143","author":[{"given":"Isabel","family":"Fofana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Fafi\u2013Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patric","family":"Carolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Fauvelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Nauman","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Turek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Heydmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Cury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Hayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Combet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois\u2013Lo\u00efc","family":"Cosset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pietschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie\u2013Sophie","family":"Hiet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Bartenschlager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Habersetzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Doffo\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen\u2013Yong","family":"Keck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven K.H.","family":"Foung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam B.","family":"Zeisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Stoll\u2013Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F.","family":"Baumert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2012.04.006_bib1","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1002\/hep.21030","article-title":"Viral hepatitis","volume":"43","author":"Alter","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2012.04.006_bib2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/nrgastro.2011.49","article-title":"A new standard of care for the treatment of chronic HCV infection","volume":"8","author":"Hofmann","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2012.04.006_bib3","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1111\/j.1600-6143.2009.02702.x","article-title":"A practical guide to the management of HCV infection following liver transplantation","volume":"9","author":"Watt","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1053\/j.gastro.2012.04.006_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/hep.22307","article-title":"Host neutralizing responses and pathogenesis of hepatitis C virus infection","volume":"48","author":"Zeisel","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2012.04.006_bib5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jhep.2010.10.014","article-title":"HCV entry into hepatocytes: mechanism and potential therapeutic implications","volume":"54","author":"Zeisel","year":"2011","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2012.04.006_bib6","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.1128\/JVI.79.10.6023-6034.2005","article-title":"Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection","volume":"79","author":"Lavillette","year":"2005","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2012.04.006_bib7","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1053\/j.gastro.2009.02.080","article-title":"Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus","volume":"136","author":"Dowd","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2012.04.006_bib8","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1084\/jem.20090766","article-title":"Enhanced viral entry and escape from antibody-mediated neutralization are key determinants for hepatitis C virus re-infection in liver transplantation","volume":"207","author":"Fafi-Kremer","year":"2010","journal-title":"J Exp Med"},{"key":"10.1053\/j.gastro.2012.04.006_bib9","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1128\/JVI.00248-09","article-title":"Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity","volume":"83","author":"Keck","year":"2009","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2012.04.006_bib10","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2012.04.006_bib11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1053\/j.gastro.2006.12.008","article-title":"Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo","volume":"132","author":"von Hahn","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2012.04.006_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1053\/j.gastro.2009.09.017","article-title":"Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection","volume":"138","author":"Osburn","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2012.04.006_bib13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are hepatitis C virus host entry factors and targets for antiviral therapy","volume":"17","author":"Lupberger","year":"2011","journal-title":"Nat Med"},{"key":"10.1053\/j.gastro.2012.04.006_bib14","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cld.2008.03.008","article-title":"Hepatitis C virus entry and neutralization","volume":"12","author":"Stamataki","year":"2008","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.gastro.2012.04.006_bib15","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/hep.21377","article-title":"A comprehensive system for consistent numbering of HCV sequences, proteins and epitopes","volume":"44","author":"Kuiken","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2012.04.006_bib16","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1053\/j.gastro.2008.07.018","article-title":"Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion","volume":"135","author":"Haberstroh","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2012.04.006_bib17","doi-asserted-by":"crossref","first-page":"10407","DOI":"10.1128\/JVI.74.22.10407-10416.2000","article-title":"Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes","volume":"74","author":"Hadlock","year":"2000","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2012.04.006_bib18","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1128\/JVI.01504-09","article-title":"Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line","volume":"84","author":"Haid","year":"2009","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2012.04.006_bib19","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1128\/JVI.01534-06","article-title":"The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells","volume":"81","author":"Koutsoudakis","year":"2007","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2012.04.006_bib20","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes","volume":"197","author":"Bartosch","year":"2003","journal-title":"J Exp Med"},{"key":"10.1053\/j.gastro.2012.04.006_bib21","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1002\/hep.21994","article-title":"Scavenger receptor BI is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81","volume":"46","author":"Zeisel","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2012.04.006_bib22","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1053\/j.gastro.2010.05.073","article-title":"Monoclonal anti-claudin 1 antibodies for prevention of hepatitis C virus infection","volume":"139","author":"Fofana","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2012.04.006_bib23","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.23445","article-title":"Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations","volume":"51","author":"Krieger","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2012.04.006_bib24","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1128\/JVI.02460-05","article-title":"Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses","volume":"80","author":"Koutsoudakis","year":"2006","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2012.04.006_bib25","doi-asserted-by":"crossref","first-page":"11095","DOI":"10.1128\/JVI.79.17.11095-11104.2005","article-title":"Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein","volume":"79","author":"Owsianka","year":"2005","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2012.04.006_bib26","first-page":"376","article-title":"Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response","volume":"119","author":"Dazert","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1053\/j.gastro.2012.04.006_bib27","doi-asserted-by":"crossref","first-page":"e1000143","DOI":"10.1371\/journal.ppat.1000143","article-title":"Stable cytotoxic T cell escape mutation in hepatitis C virus is linked to maintenance of viral fitness","volume":"4","author":"Uebelhoer","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1053\/j.gastro.2012.04.006_bib28","doi-asserted-by":"crossref","first-page":"8695","DOI":"10.1128\/JVI.00271-06","article-title":"Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding","volume":"80","author":"Owsianka","year":"2006","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2012.04.006_bib29","doi-asserted-by":"crossref","first-page":"e1000762","DOI":"10.1371\/journal.ppat.1000762","article-title":"The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule","volume":"6","author":"Krey","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1053\/j.gastro.2012.04.006_bib30","doi-asserted-by":"crossref","first-page":"9224","DOI":"10.1128\/JVI.78.17.9224-9232.2004","article-title":"Hepatitis C virus E2 has three immunogenic domains containing conformational epitopes with distinct properties and biological functions","volume":"78","author":"Keck","year":"2004","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2012.04.006_bib31","doi-asserted-by":"crossref","first-page":"8101","DOI":"10.1128\/JVI.00127-07","article-title":"The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein","volume":"81","author":"Helle","year":"2007","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2012.04.006_bib32","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.1128\/JVI.00029-06","article-title":"A conserved gly436-trp-leu-ala-gly-leu-phe-tyr motif in hepatitis C virus glycoprotein E2 is a determinant of CD81 binding and viral entry","volume":"80","author":"Drummer","year":"2006","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2012.04.006_bib33","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/BJ20110868","article-title":"Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidines of HCV glycoprotein E1 and E2","volume":"443","author":"Boo","year":"2012","journal-title":"Biochem J"},{"key":"10.1053\/j.gastro.2012.04.006_bib34","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1128\/JVI.77.3.1856-1867.2003","article-title":"Binding of the hepatitis C virus E2 glycoprotein to CD81 is strain specific and is modulated by a complex interplay between hypervariable regions 1 and 2","volume":"77","author":"Roccasecca","year":"2003","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2012.04.006_bib35","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.1128\/JVI.02782-06","article-title":"Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding","volume":"81","author":"McCaffrey","year":"2007","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2012.04.006_bib36","doi-asserted-by":"crossref","first-page":"21092","DOI":"10.1074\/jbc.M110.104836","article-title":"Claudin association with CD81 defines hepatitis C virus entry","volume":"285","author":"Harris","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1053\/j.gastro.2012.04.006_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nat Med"},{"key":"10.1053\/j.gastro.2012.04.006_bib38","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/hep.22244","article-title":"Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain","volume":"47","author":"Vanwolleghem","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2012.04.006_bib39","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1099\/vir.0.034314-0","article-title":"Comprehensive linker-scanning mutagenesis of the hepatitis C virus E1 and E2 envelope glycoproteins reveals new structure-function relationships","volume":"92","author":"Rychlowska","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1053\/j.gastro.2012.04.006_fr1","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1084\/jem.20090766","article-title":"Enhanced viral entry and escape from antibody-mediated neutralization are key determinants for hepatitis C virus re-infection in liver transplantation","volume":"207","author":"Fafi-Kremer","year":"2010","journal-title":"J Exp Med"},{"key":"10.1053\/j.gastro.2012.04.006_fr2","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2012.04.006_fr3","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/hep.23445","article-title":"Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations","volume":"51","author":"Krieger","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2012.04.006_fr4","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1073\/pnas.0504877103","article-title":"Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras","volume":"103","author":"Pietschmann","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2012.04.006_fr5","doi-asserted-by":"crossref","first-page":"13168","DOI":"10.1128\/JVI.01362-07","article-title":"Cell culture adaptation of hepatitis C virus and in vivo viability of an adapted variant","volume":"81","author":"Kaul","year":"2007","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2012.04.006_fr6","doi-asserted-by":"crossref","first-page":"44218","DOI":"10.1074\/jbc.M111.290783","article-title":"Affinity maturation to improve human monoclonal antibody neutralization potency and breadth against hepatitis C virus","volume":"286","author":"Wang","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1053\/j.gastro.2012.04.006_fr7","doi-asserted-by":"crossref","first-page":"D363","DOI":"10.1093\/nar\/gkl970","article-title":"euHCVdb: the European hepatitis C virus database","volume":"35","author":"Combet","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1053\/j.gastro.2012.04.006_fr8","doi-asserted-by":"crossref","first-page":"11095","DOI":"10.1128\/JVI.79.17.11095-11104.2005","article-title":"Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein","volume":"79","author":"Owsianka","year":"2005","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2012.04.006_fr9","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1053\/j.gastro.2008.07.018","article-title":"Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion","volume":"135","author":"Haberstroh","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2012.04.006_fr10","doi-asserted-by":"crossref","first-page":"10407","DOI":"10.1128\/JVI.74.22.10407-10416.2000","article-title":"Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes","volume":"74","author":"Hadlock","year":"2000","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2012.04.006_fr11","doi-asserted-by":"crossref","first-page":"6149","DOI":"10.1128\/JVI.00248-09","article-title":"Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity","volume":"83","author":"Keck","year":"2009","journal-title":"J Virol"},{"key":"10.1053\/j.gastro.2012.04.006_fr12","doi-asserted-by":"crossref","first-page":"16320","DOI":"10.1073\/pnas.0800156105","article-title":"Sustained delivery of siRNAs targeting viral infection by cell-degradable multilayered polyelectrolyte films","volume":"105","author":"Dimitrova","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2012.04.006_fr13","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are hepatitis C virus host entry factors and targets for antiviral therapy","volume":"17","author":"Lupberger","year":"2011","journal-title":"Nat Med"},{"key":"10.1053\/j.gastro.2012.04.006_fr14","doi-asserted-by":"crossref","first-page":"41624","DOI":"10.1074\/jbc.M305289200","article-title":"Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor","volume":"278","author":"Bartosch","year":"2003","journal-title":"J Biol Chem"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508512005094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508512005094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:39:56Z","timestamp":1762162796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508512005094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S0016508512005094"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2012.04.006","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mutations That Alter Use of Hepatitis C Virus Cell Entry Factors Mediate Escape From Neutralizing Antibodies","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2012.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}